Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors - PubMed (original) (raw)
doi: 10.1038/ng1007. Epub 2002 Sep 30.
Maarit I Tiirikainen, Chibo Hong, Anjan Misra, Burt G Feuerstein, Stanislav Volik, Colin C Collins, Kathleen R Lamborn, Andrew Bollen, Daniel Pinkel, Donna G Albertson, Joseph F Costello
Affiliations
- PMID: 12355068
- DOI: 10.1038/ng1007
Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors
Giuseppe Zardo et al. Nat Genet. 2002 Nov.
Abstract
Aberrant methylation of CpG islands and genomic deletion are two predominant mechanisms of gene inactivation in tumorigenesis, but the extent to which they interact is largely unknown. The lack of an integrated approach to study these mechanisms has limited the understanding of tumor genomes and cancer genes. Restriction landmark genomic scanning (RLGS; ref. 1) is useful for global analysis of aberrant methylation of CpG islands, but has not been amenable to alignment with deletion maps because the identity of most RLGS fragments is unknown. Here, we determined the nucleotide sequence and exact chromosomal position of RLGS fragments throughout the genome using the whole chromosome of origin of the fragments and in silico restriction digestion of the human genome sequence. To study the interaction of these gene-inactivation mechanisms in primary brain tumors, we integrated RLGS-based methylation analysis with high-resolution deletion maps from microarray-based comparative genomic hybridization (array CGH; ref. 3). Certain subsets of gene-associated CpG islands were preferentially affected by convergent methylation and deletion, including genes that exhibit tumor-suppressor activity, such as CISH1 (encoding SOCS1; ref. 4), as well as genes such as COE3 that have been missed by traditional non-integrated approaches. Our results show that most aberrant methylation events are focal and independent of deletions, and the rare convergence of these mechanisms can pinpoint biallelic gene inactivation without the use of positional cloning.
Similar articles
- The study of aberrant methylation in cancer via restriction landmark genomic scanning.
Smiraglia DJ, Plass C. Smiraglia DJ, et al. Oncogene. 2002 Aug 12;21(35):5414-26. doi: 10.1038/sj.onc.1205608. Oncogene. 2002. PMID: 12154404 Review. - Restriction landmark genomic scanning: analysis of CpG islands in genomes by 2D gel electrophoresis.
Costello JF, Hong C, Plass C, Smiraglia DJ. Costello JF, et al. Methods Mol Biol. 2009;507:131-48. doi: 10.1007/978-1-59745-522-0_11. Methods Mol Biol. 2009. PMID: 18987812 - The contribution of genetic and epigenetic mechanisms to gene silencing in oligodendrogliomas.
Hong C, Bollen AW, Costello JF. Hong C, et al. Cancer Res. 2003 Nov 15;63(22):7600-5. Cancer Res. 2003. PMID: 14633674 - Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, Andreesen R, Rehli M. Gebhard C, et al. Cancer Res. 2006 Jun 15;66(12):6118-28. doi: 10.1158/0008-5472.CAN-06-0376. Cancer Res. 2006. PMID: 16778185 - Techniques used in studies of age-related DNA methylation changes.
Wojdacz TK, Hansen LL. Wojdacz TK, et al. Ann N Y Acad Sci. 2006 May;1067:479-87. doi: 10.1196/annals.1354.069. Ann N Y Acad Sci. 2006. PMID: 16804030 Review.
Cited by
- Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression.
Ibrahim Al-Obaide MA, Arutla V, Bacolod MD, Wang W, Zhang R, Srivenugopal KS. Ibrahim Al-Obaide MA, et al. Int J Mol Sci. 2021 Mar 2;22(5):2492. doi: 10.3390/ijms22052492. Int J Mol Sci. 2021. PMID: 33801310 Free PMC article. - DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer.
Samuelsson JK, Alonso S, Yamamoto F, Perucho M. Samuelsson JK, et al. Mutat Res. 2010 Nov 10;693(1-2):61-76. doi: 10.1016/j.mrfmmm.2010.08.010. Epub 2010 Sep 17. Mutat Res. 2010. PMID: 20851135 Free PMC article. Review. - Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.
Shing DC, Trubia M, Marchesi F, Radaelli E, Belloni E, Tapinassi C, Scanziani E, Mecucci C, Crescenzi B, Lahortiga I, Odero MD, Zardo G, Gruszka A, Minucci S, Di Fiore PP, Pelicci PG. Shing DC, et al. J Clin Invest. 2007 Dec;117(12):3696-707. doi: 10.1172/JCI32390. J Clin Invest. 2007. PMID: 18037989 Free PMC article. - Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis.
Chan TA, Glockner S, Yi JM, Chen W, Van Neste L, Cope L, Herman JG, Velculescu V, Schuebel KE, Ahuja N, Baylin SB. Chan TA, et al. PLoS Med. 2008 May 27;5(5):e114. doi: 10.1371/journal.pmed.0050114. PLoS Med. 2008. PMID: 18507500 Free PMC article. - A sequence-based survey of the complex structural organization of tumor genomes.
Raphael BJ, Volik S, Yu P, Wu C, Huang G, Linardopoulou EV, Trask BJ, Waldman F, Costello J, Pienta KJ, Mills GB, Bajsarowicz K, Kobayashi Y, Sridharan S, Paris PL, Tao Q, Aerni SJ, Brown RP, Bashir A, Gray JW, Cheng JF, de Jong P, Nefedov M, Ried T, Padilla-Nash HM, Collins CC. Raphael BJ, et al. Genome Biol. 2008;9(3):R59. doi: 10.1186/gb-2008-9-3-r59. Epub 2008 Mar 25. Genome Biol. 2008. PMID: 18364049 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases